CM Yogi Congratulates Dr Rajendra Prasad on Padma Shri
Synopsis
Uttar Pradesh Chief Minister Yogi Adityanath congratulated senior physician Prof. (Dr.) Rajendra Prasad on receiving the Padma Shri from President Draupadi Murmu, honouring five decades of selfless service in tuberculosis and MDR-TB treatment and his contribution to public health across India.
Key Takeaways
CM Yogi Adityanath publicly congratulated Prof. (Dr.) Rajendra Prasad on being awarded the Padma Shri on 25 May 2026 .
The award was conferred by President Draupadi Murmu at a ceremony in New Delhi .
Prasad has worked in TB and MDR-TB treatment for over five decades , providing care to lakhs of patients.
The Padma Shri is India's fourth-highest civilian honour , awarded annually for distinguished service.
India's National TB Elimination Programme has set a target of eliminating tuberculosis, reflecting the disease's status as a long-standing national public-health priority.
Uttar Pradesh Chief Minister Yogi Adityanath on Monday, 25 May 2026 congratulated senior physician Prof. (Dr.) Rajendra Prasad on being conferred the Padma Shri — India's fourth-highest civilian honour — by President Draupadi Murmu at a ceremony in New Delhi, recognising his five decades of work in tuberculosis and multidrug-resistant TB treatment.
Context
In his post, CM Yogi extended heartfelt congratulations, writing: 'TB एवं MDR-TB उपचार के क्षेत्र में पिछले पांच दशकों की आपकी निस्वार्थ एवं समर्पित सेवा सराहनीय है' ('Your selfless and dedicated service of the past five decades in the field of TB and MDR-TB treatment is commendable'). He added that Dr. Prasad's outstanding contribution to public health — giving 'new life to lakhs of patients' — is a matter of great pride for the entire nation.
The Chief Minister described the honour as a recognition of 'the highest values of service, dedication, and humanity in the world of medicine.' President Draupadi Murmu conferred the award as part of the annual Padma Awards investiture ceremony held in New Delhi.
Policy Backdrop
Tuberculosis has remained one of India's most persistent public-health challenges. The government launched the Revised National Tuberculosis Control Programme (RNTCP) in 1997, expanding access to free Directly Observed Treatment Short-course (DOTS) across the country. India subsequently set an ambitious target of TB elimination by 2025 under the National TB Elimination Programme.
Multidrug-resistant TB, or MDR-TB, presents a particularly complex clinical challenge requiring prolonged and expensive treatment regimens. Physicians who have dedicated careers to this sub-speciality are considered especially significant to the national elimination effort.
Stakeholders and Impact
The Padma Shri conferred on Dr. Rajendra Prasad carries symbolic weight for the medical community working on infectious diseases, signalling continued state endorsement of sustained grassroots health service. For the millions of TB patients treated over his five-decade career, the recognition affirms the value of long-term clinical commitment over institutional or corporate medical practice.
State leaders publicly acknowledging national civilian awardees — as CM Yogi has done here — reinforces the political salience of public-health contributions and can encourage younger medical professionals to pursue careers in under-resourced disease-control programmes.
What's Next
The National TB Elimination Programme continues to publish periodic updates on case detection and treatment outcomes as India works toward its elimination goals. The next annual Padma Awards list, typically announced around Republic Day each year, will again spotlight individuals making long-term contributions across sectors. Dr. Prasad's recognition is likely to draw renewed attention to the need for sustained investment in TB research and frontline clinical capacity.
Point of View
Particularly in the health sector — a low-cost, high-visibility gesture that aligns the ruling dispensation with grassroots public service. The specific mention of five decades of TB and MDR-TB work is notable given that India has staked significant political capital on its TB elimination targets. By foregrounding Dr. Prasad's contribution, the post implicitly reinforces the government's narrative that the fight against tuberculosis is a national mission deserving both clinical commitment and state recognition. The tribute also subtly signals to the medical community that sustained, unglamorous work in infectious disease control carries political as well as institutional value.
NationPress
11 Jul 2026
Frequently Asked Questions
Who is Prof. (Dr.) Rajendra Prasad who received the Padma Shri?
Prof. (Dr.) Rajendra Prasad is a senior Indian physician recognised for over five decades of work in tuberculosis and multidrug-resistant TB treatment, for which he was conferred the Padma Shri by President Draupadi Murmu in 2026.
What is the Padma Shri award?
The Padma Shri is India's fourth-highest civilian honour, awarded annually by the President of India to recognise distinguished service in fields including medicine, arts, science, and public affairs.
Why did CM Yogi congratulate Dr Rajendra Prasad?
CM Yogi Adityanath congratulated Dr. Rajendra Prasad on being conferred the Padma Shri for his outstanding and selfless contribution to TB and MDR-TB treatment over five decades, which the Chief Minister described as a matter of national pride.
What is MDR-TB and why is it significant in India?
MDR-TB, or multidrug-resistant tuberculosis, is a form of TB that does not respond to the standard first-line drugs, making treatment more complex and prolonged. India has prioritised its elimination as part of the broader National TB Elimination Programme.
What is India's target for TB elimination?
India set a target of eliminating tuberculosis by 2025 under the National TB Elimination Programme, an ambition that has made sustained clinical contributions to TB control especially significant in public-health policy.
